Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type 1 selected

Type

Guidance programme

Showing 1 to 115 of 115

TitleReference numberPublishedLast updated
Pegylated liposomal irinotecan for treating pancreatic cancer after gemcitabineTA440
Ixekizumab for treating moderate to severe plaque psoriasisTA442
Obeticholic acid for treating primary biliary cholangitisTA443
Antisocial behaviour and conduct disorders in children and young people: recognition and managementCG158
Alcohol-use disorders: diagnosis and management of physical complicationsCG100
Sexually transmitted infections: condom distribution schemesNG68
Minimally invasive sacroiliac joint fusion surgery for chronic sacroiliac painHTG436
Irritable bowel syndrome in adults: diagnosis and managementCG61
Managing medicines for adults receiving social care in the communityNG67
Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal)TA240
Alectinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (terminated appraisal)TA438
Patient group directionsMPG2
Tenofovir alafenamide for treating chronic hepatitis B (terminated appraisal)TA435
Bevacizumab for treating EGFR mutation-positive non-small-cell lung cancer (terminated appraisal)TA436
Ibrutinib with bendamustine and rituximab for treating relapsed or refractory chronic lymphocytic leukaemia after systemic therapy (terminated appraisal)TA437
Elotuzumab for previously treated multiple myeloma (terminated appraisal)TA434
Extraurethral (non-circumferential) retropubic adjustable compression devices for stress urinary incontinence in womenHTG434
Sacrocolpopexy with hysterectomy using mesh to repair uterine prolapseHTG435
Mental health of adults in contact with the criminal justice systemNG66
Ustekinumab for treating active psoriatic arthritisTA340
Ustekinumab for treating moderate to severe plaque psoriasisTA180
Molecular testing strategies for Lynch syndrome in people with colorectal cancerHTG430
Migalastat for treating Fabry diseaseHST4
Drug misuse prevention: targeted interventionsNG64
Everolimus for advanced renal cell carcinoma after previous treatmentTA432
Apremilast for treating active psoriatic arthritisTA433
Lateral interbody fusion in the lumbar spine for low back painHTG431
Trabecular stent bypass microsurgery for open-angle glaucomaHTG432
Healthcare-associated infections: prevention and control in primary and community careCG139
HumiGard for preventing inadvertent perioperative hypothermiaHTG428
Osteoporosis: assessing the risk of fragility fractureCG146
Cerebral palsy in under 25s: assessment and managementNG62
Antimicrobial stewardship: changing risk-related behaviours in the general populationNG63
Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutationTA429
Sofosbuvir–velpatasvir for treating chronic hepatitis CTA430
Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomibTA427
Organ donation for transplantation: improving donor identification and consent rates for deceased organ donationCG135
Everolimus with exemestane for treating advanced breast cancer after endocrine therapyTA421
Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerTA422
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimensTA423
Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancerTA424
Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemiaTA425
Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemiaTA426
Extracorporeal shockwave therapy for Achilles tendinopathyHTG426
Radiation therapy for early Dupuytren's diseaseHTG427
Hypothermia: prevention and management in adults having surgeryCG65
Ticagrelor for preventing atherothrombotic events after myocardial infarctionTA420
Epiduroscopic lumbar discectomy through the sacral hiatus for sciaticaHTG425
XprESS multi sinus dilation system for treating chronic sinusitisHTG424
Recent-onset chest pain of suspected cardiac origin: assessment and diagnosisCG95
Coexisting severe mental illness and substance misuse: community health and social care servicesNG58
Spasticity in under 19s: managementCG145
Nivolumab for previously treated advanced renal cell carcinomaTA417
Dapagliflozin in triple therapy for treating type 2 diabetesTA418
Apremilast for treating moderate to severe plaque psoriasisTA419
Dapagliflozin in combination therapy for treating type 2 diabetesTA288
Endoscopic transluminal pancreatic necrosectomyHTG421
Percutaneous insertion of craniocaudal expandable implants for vertebral compression fractureHTG422
Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy for treating morbid obesityHTG423
High-throughput non-invasive prenatal testing for fetal RHD genotypeHTG420
Physical health of people in prisonNG57
Psychosis and schizophrenia in children and young people: recognition and managementCG155
Elbasvir–grazoprevir for treating chronic hepatitis CTA413
Cobimetinib in combination with vemurafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanomaTA414
Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitorTA415
Single-incision short sling mesh insertion for stress urinary incontinence in womenHTG419
Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusionTA409
Talimogene laherparepvec for treating unresectable metastatic melanomaTA410
Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancerTA411
Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastasesTA412
Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerTA406
Pegaspargase for treating acute lymphoblastic leukaemiaTA408
Secukinumab for treating active ankylosing spondylitisTA407
Miniature lens system implantation for advanced age-related macular degenerationHTG418
Multimorbidity: clinical assessment and managementNG56
Harmful sexual behaviour among children and young peopleNG55
Mental health problems in people with learning disabilities: prevention, assessment and managementNG54
Transition between inpatient mental health settings and community or care home settingsNG53
Stable angina: managementCG126
Acute upper gastrointestinal bleeding in over 16s: managementCG141
Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxelTA391
Trifluridine–tipiracil for previously treated metastatic colorectal cancerTA405
Bosutinib for previously treated chronic myeloid leukaemiaTA401
Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatinTA402
Ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancerTA403
Degarelix for treating advanced hormone-dependent prostate cancerTA404
Palliative care for adults: strong opioids for pain reliefCG140
Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicatedTA387
Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blastsTA399
Nivolumab in combination with ipilimumab for treating advanced melanomaTA400
Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimenTA259
Percutaneous endoscopic laser balloon pulmonary vein isolation for atrial fibrillationHTG417
Non-Hodgkin's lymphoma: diagnosis and managementNG52
Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional proceduresCG64
Non-alcoholic fatty liver disease (NAFLD): assessment and managementNG49
Oral health for adults in care homesNG48
Adalimumab for treating moderate to severe hidradenitis suppurativaTA392
Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemiaTA393
Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemiaTA394
Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancerTA395
Trametinib in combination with dabrafenib for treating unresectable or metastatic melanomaTA396
Transcervical extracorporeal reverse flow neuroprotection for reducing the risk of stroke during carotid artery stentingHTG415
Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodulesHTG416
Haematological cancers: improving outcomesNG47
Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetesTA390
Endovenous mechanochemical ablation for varicose veinsHTG414
ImmunoCAP ISAC 112 for multiplex allergen testingHTG413
Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fractionTA388
Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancerTA389
Microwave ablation for treating liver metastasesHTG409
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertensionHTG410
Percutaneous interlaminar endoscopic lumbar discectomy for sciaticaHTG411
Percutaneous transforaminal endoscopic lumbar discectomy for sciaticaHTG412
Controlled drugs: safe use and managementNG46
Routine preoperative tests for elective surgeryNG45

Results per page

  1. 10
  2. 25
  3. 50
  4. All